Current paradigms and novel strategies in paediatric

ESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHAN
ESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHAN
European Society for
Paediatric Gastroenterology,
Hepatology and Nutrition
Conference fees
16.30h-18.30h AB0 incompatible donors
Khalid Sharif, Birmingham, UK
Patrick Gerner, Essen, Germany
Withdrawal of immune suppression after liver transplantation: current understanding of tolerance and clinical trials – facts and round table discussion and working group:
requirements for joint approach
Immunosuppression
Sandy Feng, San Francisco, USA
George Mazariegos, Pittsburgh, USA
Including registration for conference,
accommondation and meals
200,- € allied health professional (with supporting letter)
300,- € trainees (with supporting letter)
400,- € early bird
500,- € any late bookings, from 15.08.2013
summary of the day
Ulrich Baumann, MD
Hannover Medical School
Paediatric Gastroenterology and Hepatology
Carl Neuberg Str 1, 30625 Hannover, Germany
[email protected]
20.00h Dinner Saturday, 14th Sep 2013
Donor organ shortage and novel indications
7.30h Breakfast
8.30h-11.00h How to improve organ allocation – learning from our neighbours: National experiences with cadaveric and live-related organ donation
John Bucuvalas, Cincinnati, USA
Ozlem Durmaz, Istanbul, Turkey
Esteban Frauca, Madrid, Spain
Antal Dezsofi, Budapest, Hungary
Björn Fischler, Stockholm, Sweden
11.00h-11.30h Coffee break
11.30h-13.00h Challenging indications for liver transplantation: Urea cycle defects Patrick McKiernan, Birmingham, UK
Mitochondrial disorders
Nedim Hadzic, London, UK
Malignancies
Barbara Wildhaber, Geneva, Switzerland
Maple syrup urinary disease
George Mazariegos, Pittsburgh, USA
Registration and further Information
www.espghan.org
Contact Information
Courtyard Hannover Maschsee
Arthur-Menge-Ufer 3, 30169 Hannover, Germany
www.marriott.de/hotels/travel/hajcy-courtyard-hannover-maschsee
Supported by the following organisations:
10.000€
Supported by Astellas Pharma GmbH with a sponsoring of 15.000€
10.000€
summary of the day
13.00h Farewell and Lunch
10.000€
Current paradigms and
novel strategies
in paediatric liver
transplantation
12th − 14th September 2013
Place of Conference
2000€
Monothematic conference
ESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHAN
ESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHAN
Dear colleagues
It is with great pleasure that we invite you to the first ESPGHAN
monothematic conference on paediatric liver transplantation!
Thursday, 12th Sep 2013
Friday, 13th Sep 2013
Improving late outcome of liver tx
Immunology
From 11.30h 7.30h Coffee
8.00h
Overview: Transplant immunology and tolerance
Christine Falk, Hannover, Germany
8.30h-9.00h PTLD and malignancy
Stefan Gottschalk, Houston, USA
Britta Maecker-Kolhoff, Hannover, Germany
From 12.00h Lunch
Over the last 25 years paediatric liver transplantation has emerged
from an experimental concept to established medical therapy. This
successful development forces us to continuously consider new
approaches to further improve the care of liver transplanted
children.
This monothematic conference on paediatric liver transplantation is
organized on behalf of the ESPGHAN Hepatology Committee. The
focus will be on improving late outcomes and organ allocation
strategies, transplant immunology, and new and challenging
indications. Single centre experiences, pro- and con debates, as well
as deeper reviews will be presented, with the primary objective to
encourage constructive discussions. We aim to provide both, a
statement of current expertise and discussions on future prospects
in our field!
We look forward to welcoming you to Hannover!
for the ESPGHAN hepatology committee:
Ulrich Baumann
Hannover
Piotr Socha, Warsaw
Antal Dezsofi, Budapest
Ozlem Durmaz, Istanbul
Nedim Hadzic, London
Loreto Hierro, Madrid
Valerio Nobili, Rome
Pietro Vajro, Salerno
Björn Fischler
Stockholm
Valerie McLin
Geneva
13.45h Welcome
14.00h-14.20h Overview of long term outcome:
Survival and ELTR data
Vincent Karam, Paris, France
14.20h-16.30h Centre experience, multiple presentations:
Long term QoL, cognitive and neurodevel
opmental outcome
Dominique Debray, Paris, France
Vicky Ng, Toronto, Canada
Infection and sepsis
NN
Cardiovascular complications
Valerie McLin, Geneva, Switzerland
Annette Melk, Hannover, Germany
Renal comorbidity and need for kidney
transplantation
NN
16.30h-17.00h Coffee break
17.00h-18.30h Centre presentations, cont.
Portal hypertension after liver transplantation: causes and approach
Lorenzo d'Antiga, Bergamo, Italy
Jean de Ville de Goyet, Rome, Italy
Cholangiopathies after liver transplantation: causes and approach
Michele Colledan, Bergamo, Italy
Stephanie Franchi, Paris, France
Nikolas Richter, Hannover, Germany
summary of the day
20.00h Dinner Breakfast
9.00h-11.00h Steroid-free immunosuppression: Clinical trials and case series
Raymond Reding, Brussels, Belgium
Marco Sciveres, Palermo, Italy
Ulrich Baumann, Hannover, Germany
Experience with Calcineurin-inhibitor sparing regimen
Patrick McKiernan, Birmingham, UK
Funda Ozgenç, Izmir, Turkey
mTOR inhibitor based immunosuppression: Paediatric and adult experience
Anil Dhawan, London, UK
Rainer Ganschow, Hamburg, Germany
Christian Toso, Geneva, Switzerland
11.00h-11.30h Coffee break
11.30h-12.30 Role of donor specific antibodies in liver transplantation
Loreto Hierro, Madrid, Spain
Dendritic cell therapy and other strategies to induce tolerance
Marie Cristina Cuturi, Nantes, France
12.30h-14.00h Lunch
14.00h-16.00h de novo – autoimmune hepatitis vs. rejection in liver biopsies post liver transplantation
Stefan Hübscher, Birmingham, UK
Protocol biopsies in paediatric liver transplantation
Deirdre Kelly, Birmingham, UK
Simon Horslen, Seattle, USA
16.00h-16.30h Coffee break